IT1126405B - Derivati esteri dell'acido farnesilacetico - Google Patents

Derivati esteri dell'acido farnesilacetico

Info

Publication number
IT1126405B
IT1126405B IT27613/79A IT2761379A IT1126405B IT 1126405 B IT1126405 B IT 1126405B IT 27613/79 A IT27613/79 A IT 27613/79A IT 2761379 A IT2761379 A IT 2761379A IT 1126405 B IT1126405 B IT 1126405B
Authority
IT
Italy
Prior art keywords
farnesilacetic
acid
foreign
derivatives
foreign derivatives
Prior art date
Application number
IT27613/79A
Other languages
English (en)
Other versions
IT7927613A0 (it
Inventor
Susumu Okabe
Yoshiaki Omura
Yoichi Ninagawa
Yoshiji Fujita
Original Assignee
Kuraray Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Co filed Critical Kuraray Co
Publication of IT7927613A0 publication Critical patent/IT7927613A0/it
Application granted granted Critical
Publication of IT1126405B publication Critical patent/IT1126405B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IT27613/79A 1978-11-28 1979-11-27 Derivati esteri dell'acido farnesilacetico IT1126405B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14762278A JPS5573642A (en) 1978-11-28 1978-11-28 Farnesyl-acetic ester derivative

Publications (2)

Publication Number Publication Date
IT7927613A0 IT7927613A0 (it) 1979-11-27
IT1126405B true IT1126405B (it) 1986-05-21

Family

ID=15434480

Family Applications (1)

Application Number Title Priority Date Filing Date
IT27613/79A IT1126405B (it) 1978-11-28 1979-11-27 Derivati esteri dell'acido farnesilacetico

Country Status (7)

Country Link
US (1) US4289786A (it)
JP (1) JPS5573642A (it)
CH (1) CH646411A5 (it)
DE (1) DE2947775A1 (it)
FR (1) FR2442829A1 (it)
GB (1) GB2039476B (it)
IT (1) IT1126405B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120916A1 (de) * 1991-06-25 1993-01-07 Basf Ag Omega-3 mehrfach ungesaettigte fettsaeurederivate, ihre herstellung und verwendung
WO1995008976A1 (en) * 1993-09-30 1995-04-06 The Procter & Gamble Company Active substance delivery system
US6005086A (en) * 1995-01-13 1999-12-21 The Salk Institute For Biological Studies Farnesoid activated receptor polypeptides, and nucleic acid encoding the same
JP2002519305A (ja) * 1998-06-24 2002-07-02 メルク エンド カムパニー インコーポレーテッド 骨吸収阻害用の組成物および方法
AU2002214267A1 (en) * 2000-11-08 2002-05-21 Santen Pharmaceutical Co. Ltd. Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB938712A (en) * 1961-05-24 1963-10-02 Angeli Inst Spa Farnesyl acetic esters
CA970365A (en) 1972-07-14 1975-07-01 Princeton Biomedix Pharmaceutically useful compounds and methods of producing and using same
US3928403A (en) * 1974-07-10 1975-12-23 Kuraray Co Process for preparing farnesyl acetic acid esters and 2-substituted-products thereof
JPS5855129B2 (ja) * 1974-11-21 1983-12-08 株式会社クラレ 2−置換または無置換のゲラニル酢酸エステル類の製造方法

Also Published As

Publication number Publication date
FR2442829A1 (fr) 1980-06-27
CH646411A5 (fr) 1984-11-30
DE2947775C2 (it) 1987-08-27
DE2947775A1 (de) 1980-05-29
JPS5573642A (en) 1980-06-03
GB2039476A (en) 1980-08-13
IT7927613A0 (it) 1979-11-27
US4289786A (en) 1981-09-15
GB2039476B (en) 1982-09-22
FR2442829B1 (it) 1983-07-18
JPS6123178B2 (it) 1986-06-04

Similar Documents

Publication Publication Date Title
IT1166909B (it) Derivati dell'acido chinolin*carbossilico sostituiti
IT1097233B (it) Nuovi derivati dell'acido fenilacetico
IT1202822B (it) Derivati esterei dell'acido n-acetil-para-aminofenolico e loro preparazione
IT1138193B (it) Derivati dell'acido carbammico
IT1170915B (it) Derivati sostituiti dell'acido 4-fenil-4-osso-2-butenoico aventi proprieta' farmaceutiche
IT1124869B (it) Procedimento per la produzione di derivati dell'acido fenossicarbossilico
IT8123108A1 (it) Nuovi derivati dell'acido ursodesossicolico
IT1198389B (it) Esteri dell'acido 3-metilflavone-8-carbossilico
IT1167479B (it) Derivati dell'acido chenodesossicolico
IT1150726B (it) Derivati dell'acido ascorbico
IT1126405B (it) Derivati esteri dell'acido farnesilacetico
IT1170914B (it) Derivati sostituiti dell'acido 4-fenil-4-osso-2-idrossibutanoico aventi proprieta' farmaceutiche
IT1134423B (it) Procedimento per la preparazione di derivati di esteri dell'acido apovincaminico
IT1157325B (it) Esteri dell'acido antranilico
IT1122310B (it) Derivati dell'acido tio-propanoilamminico
IT7849300A0 (it) Derivati dell'acido 2-triclorometil4-nitrobenzolsolfenico
IT1121530B (it) Nuovi derivati dell'acido 1-pirrolo-e 1-pirrolidin-carbossilico e procedimento per la loro preparazione
IT1141125B (it) Derivati dell'acido carbotioico di mercaptoacilamminocidi
IT7909322A0 (it) Un procedimento per la produzione dell acido 4 amminobutirico e suoi derivati
IT1168089B (it) Procedimento per la preparazione di derivati dell'acido penem-3-carbossilico
IT1195761B (it) Derivati dell'acido ossayohimban-carbossilico
IT1137454B (it) Derivati dell'acido benzaminoetilfenossicicloesilacetico
IT1081510B (it) Derivati dell'acido 2-cianoesanoico
IT1095451B (it) Esteri dell'acido ciclopropancarbossilico
IT1150960B (it) Derivati dell'acido 4-tiazolidincarbossilico